Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with dementia

dementia risk4 - hormone replacement therapy1 - neurofilaments1 - alcohol related dementia1 - sleep tied to alzheimer's1 - development of parkinson's1 - protease enzyme1 - cytokine storm1 - elderly people1 - amyloid plaques13 - tuberculosis1 - memory losses1 - multiple system atrophy1 - body mass index2 - parkinson's diseases1 - apoplectic dementia1 - good sleep habits1 - mild dementia2 - reverse cholesterol transport1 - hypertension3 - rem-sleep behavior disorder1 - abnormal tau protein1 - cannabinoid receptors1 - head injuries1 - blast-induced traumatic brain injury1 - learning skills1 - senility1 - cognition2 - medical history1 - alzheimers and parkinsons1 -